Componenta (CTH1V) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for January–September 2024 were EUR 70.3 million, down 12% year-over-year from EUR 80.1 million.
EBITDA declined to EUR 3.1 million from EUR 5.8 million, a 46% decrease.
Operating result was EUR -0.9 million, compared to EUR 5.7 million last year, which included a one-off gain of EUR 4.2 million.
Q3 2024 showed improvement: net sales rose to EUR 20.3 million and EBITDA increased to EUR 1.2 million.
Order book at period end was EUR 13.9 million, up EUR 3.1 million from June 2024.
Financial highlights
Net result Jan–Sep 2024: EUR -2.7 million (EUR 4.1 million); basic EPS: EUR -0.27 (EUR 0.43).
Cash flow from operations Jan–Sep 2024: EUR 1.0 million, down from EUR 2.7 million.
Cash and cash equivalents at period end were EUR 6.4 million, down from EUR 8.3 million.
Unused binding revolving credit facilities totaled EUR 2.0 million.
Interest-bearing net debt: EUR 10.3 million (EUR 5.8 million); equity ratio: 40.1% (46.5%).
Outlook and guidance
Net sales and EBITDA are expected to improve from the previous year (2023 net sales EUR 101.8 million, EBITDA EUR 5.3 million).
Growth expectations for most customers postponed to 2025; current order book and product portfolio support 2024 guidance.
Focus areas include growth, profitability, and ramp-up of new serial production.
Latest events from Componenta
- Net sales and profitability surged, with strong cash and order book growth supporting a positive outlook.CTH1V
Q4 20256 Mar 2026 - Sales and EBITDA surged, order book grew, and liquidity stayed stable amid uncertainty.CTH1V
Q3 202530 Oct 2025 - Sales and profit surged, led by energy and defence, with strong cash flow and positive outlook.CTH1V
Q2 202523 Jul 2025 - Sales and profit fell, but new contracts and acquisitions signal recovery in H2 2024.CTH1V
Q2 202413 Jun 2025 - Sales and profitability surged, with strong liquidity and a positive outlook for 2025.CTH1V
Q1 20255 Jun 2025 - EBITDA and cash flow surged despite lower net sales, with a strong order book and positive outlook.CTH1V
Q4 20245 Jun 2025